Genetic Signatures Ltd.ASX: GSS

BCAL Welcomes Dr John Melki's Appointment to GSS Board

· Issued by Genetic Signatures Ltd. via ASX

Filed with ASX · · 2 pages · English

On 6ix: 6ix.com/news/bcal-welcomes-dr-john-melkis-appointment-to-gss-board-1

Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings Call

Release

ASX Announcement 28 October 2026 BCAL welcomes Dr John Melki’s appointment to GSS Board and reiterates merger concerns BCAL Diagnostics Limited (ASX: BDX) (BCAL), an Australian healthcare company pioneering diagnostics for early detection of cancer. BCAL a major shareholder in Genetic Signatures...

Genetic Signatures Ltd. on 6ix

Earlier from Genetic Signatures

Later from Genetic Signatures

All Genetic Signatures news releases